AJOVista LLC Invests $58,000 in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

AJOVista LLC acquired a new stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,630 shares of the company’s stock, valued at approximately $58,000. Other institutional investors also recently added to […]

Related Keywords

China ,Marc Wilson ,Robertw Baird ,Richard Scott Struthers ,York Mellon Corp ,Insider Transactions At Crinetics Pharmaceuticals ,Crinetics Pharmaceuticals Inc ,News Ratings For Crinetics Pharmaceuticals Daily ,Exchange Commission ,Hennion Walsh Asset Management Inc ,Citigroup ,Nasdaq ,Crinetics Pharmaceuticals Stock Performance ,Quarter For Crinetics Pharmaceuticals ,Crinetics Pharmaceuticals ,Mirae Asset Global Investments Co ,China Universal Asset Management Co ,Securities Exchange Commission ,Td Asset Management Inc ,Free Report ,New York Mellon Corp ,Asset Global Investments ,Management Inc ,Walsh Asset Management ,China Universal Asset Management ,Universal Asset Management ,Scott Struthers ,Get Free Report ,Visit Holdingschannel ,Crinetics Pharmaceuticals Daily ,Nasdaq Crnx ,Crnx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,